Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

GIP glucose-dependent

Antidiabetic Drugs other than Insulin. Table 3 Actions of the incretin hormones GIP (glucose-dependent insulinotropic polypeptide, gastric inhibitory peptide) and GLP-1 (glucagon-like peptide-1)... [Pg.122]

ARDS adnlt respiratory distress syndrome GIP glucose-dependent insulinotrophic... [Pg.560]

Sitagliptin is a selective dipeptidylpeptidase 4 (DPP-4) inhibitor which increases the active form of GLP-1 (glucagon-like-peptide-1) and GIP (glucose-dependent insulinotropic peptide). This enzyme-inhibiting drug is to be used either alone or in combination with metformin or a thiazolidinedione for control of type 2 diabetes mellitus. Adverse effects were as common with sitagliptin (whether used alone or with metformin or pioglitazone) as they were with placebo, except for nausea and common cold-like symptoms. [Pg.397]

GIP Glucose-dependent-insulinotropic polypeptide = Gastric inhibitory peptide... [Pg.253]

GIP, gastric inhibitory peptide, glucose-dependent insulinotropic. polypeptide Glc, (3-D-gluc.ose... [Pg.842]

Glucose-dependent insulinotropic polypeptide (GIP) GIP receptor 42-residue peptide Inhibit gastric acid and stimulate insulin secretion Solution-phase chemistry... [Pg.2181]

Glucose-dependent insulinotropic polypeptide is originally known as gastric inhibitory polypeptide (GIP), which is a 42-residue peptide first isolated by Brown and Dryburgh (14). It is secreted from the duodenum and proximal jejunum in response to food. Two major physiological effects of GIP are inhibition of gastric acid secretion and stimulation of insulin release. [Pg.2187]

Human-glucose-dependent insulinotropic polypeptide (human GIP) was synthesized by the route shown in Scheme Trimethylsilyl trifluoromethanesulfonate (TMSOTf) has also... [Pg.622]

Postprandial glucose-dependent insulinotropic polypeptide (GIP) levels were lowered in a guar-gum-supplemented meal (Morgan et al., 1990) and may contribute to lower insulin levels. Guar delays intestinal calcium absorption in humans (Gulliford et al., 1988b). The decrease in pancreatic amylase release may simply be a result of diminished insular-exocrine axis. [Pg.152]

Glucose-Dependent Insulinotropic Peptide (GIP, Gastric Inhibitory Polypeptide) ... [Pg.1876]

Glucose-Dependent Insulinotropic Polypeptide (GIP) Analogs (Incretin Hormone Analog o-Ala2GIP)... [Pg.442]

See other pages where GIP glucose-dependent is mentioned: [Pg.121]    [Pg.417]    [Pg.255]    [Pg.121]    [Pg.126]    [Pg.142]    [Pg.57]    [Pg.622]    [Pg.244]    [Pg.121]    [Pg.417]    [Pg.255]    [Pg.121]    [Pg.126]    [Pg.142]    [Pg.57]    [Pg.622]    [Pg.244]    [Pg.657]    [Pg.98]    [Pg.131]    [Pg.132]    [Pg.541]    [Pg.542]    [Pg.401]    [Pg.757]    [Pg.341]    [Pg.930]    [Pg.947]    [Pg.386]    [Pg.388]    [Pg.69]    [Pg.126]    [Pg.165]    [Pg.24]    [Pg.2187]    [Pg.99]    [Pg.1876]    [Pg.442]   


SEARCH



© 2024 chempedia.info